156 related articles for article (PubMed ID: 28051255)
1. Down-regulation of long non-coding RNA MEG3 serves as an unfavorable risk factor for survival of patients with breast cancer.
Zhang JJ; Guo SH; Jia BQ
Eur Rev Med Pharmacol Sci; 2016 Dec; 20(24):5143-5147. PubMed ID: 28051255
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of long non-coding RNA MEG3 indicates an unfavorable prognosis in non-small cell lung cancer: Evidence from the GEO database.
Zhang Z; Liu T; Wang K; Qu X; Pang Z; Liu S; Liu Q; Du J
Gene; 2017 Sep; 630():49-58. PubMed ID: 28782577
[TBL] [Abstract][Full Text] [Related]
3. Decreased expression of long non-coding RNA MEG3 acts as a potential predictor biomarker in progression and poor prognosis of osteosarcoma.
Tian ZZ; Guo XJ; Zhao YM; Fang Y
Int J Clin Exp Pathol; 2015; 8(11):15138-42. PubMed ID: 26823857
[TBL] [Abstract][Full Text] [Related]
4. LncRNA MEG3 inhibits cell epithelial-mesenchymal transition by sponging miR-421 targeting E-cadherin in breast cancer.
Zhang W; Shi S; Jiang J; Li X; Lu H; Ren F
Biomed Pharmacother; 2017 Jul; 91():312-319. PubMed ID: 28463794
[TBL] [Abstract][Full Text] [Related]
5. Expression of long non-coding RNA linc-ITGB1 in breast cancer and its influence on prognosis and survival.
Li WX; Sha RL; Bao JQ; Luan W; Su RL; Sun SR
Eur Rev Med Pharmacol Sci; 2017 Aug; 21(15):3397-3401. PubMed ID: 28829502
[TBL] [Abstract][Full Text] [Related]
6. Hypermethylation of lncRNA MEG3 impairs chemosensitivity of breast cancer cells.
Li H; Wang P; Liu J; Liu W; Wu X; Ding J; Kang J; Li J; Lu J; Pan G
J Clin Lab Anal; 2020 Sep; 34(9):e23369. PubMed ID: 32618397
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of long non-coding RNA CCAT1 is a novel biomarker of poor prognosis in patients with breast cancer.
Zhang XF; Liu T; Li Y; Li S
Int J Clin Exp Pathol; 2015; 8(8):9440-5. PubMed ID: 26464701
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of MEG3 contributes to retinoblastoma progression and affects retinoblastoma cell growth by regulating the activity of Wnt/β-catenin pathway.
Gao Y; Lu X
Tumour Biol; 2016 Feb; 37(2):1461-9. PubMed ID: 26662307
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of the long non-coding RNA SPRY4-IT1 predicts poor prognosis in breast cancer.
Xiang Y; Chen Y; Shi Y; Wu X; Hao R; Li Q; Li D
Int J Clin Exp Pathol; 2019; 12(3):1003-1008. PubMed ID: 31933911
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of long noncoding RNA MEG3 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer.
Yin DD; Liu ZJ; Zhang E; Kong R; Zhang ZH; Guo RH
Tumour Biol; 2015 Jun; 36(6):4851-9. PubMed ID: 25636452
[TBL] [Abstract][Full Text] [Related]
11. Mining Prognostic Significance of MEG3 in Human Breast Cancer Using Bioinformatics Analysis.
Cui X; Yi Q; Jing X; Huang Y; Tian J; Long C; Xiang Z; Liu J; Zhang C; Tan B; Li Y; Zhu J
Cell Physiol Biochem; 2018; 50(1):41-51. PubMed ID: 30278461
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of long noncoding RNA MEG3 is associated with poor prognosis and promoter hypermethylation in cervical cancer.
Zhang J; Lin Z; Gao Y; Yao T
J Exp Clin Cancer Res; 2017 Jan; 36(1):5. PubMed ID: 28057015
[TBL] [Abstract][Full Text] [Related]
13. Association analyses of a genetic variant in long non-coding RNA MEG3 with breast cancer susceptibility and serum MEG3 expression level in the Egyptian population.
Ali MA; Shaker OG; Alazrak M; AbdelHafez MN; Khalefa AA; Hemeda NF; Abdelmoktader A; Ahmed FA
Cancer Biomark; 2020; 28(1):49-63. PubMed ID: 32176630
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of long noncoding RNA HOTTIP on clinical outcomes in breast cancer.
Yang Y; Qian J; Xiang Y; Chen Y; Qu J
Oncotarget; 2017 Jan; 8(4):6833-6844. PubMed ID: 28036281
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA MEG3, a potential novel biomarker to predict the clinical outcome of cancer patients: a meta-analysis.
Cui X; Jing X; Long C; Tian J; Zhu J
Oncotarget; 2017 Mar; 8(12):19049-19056. PubMed ID: 28157702
[TBL] [Abstract][Full Text] [Related]
16. A novel long non-coding RNA FGF14-AS2 is correlated with progression and prognosis in breast cancer.
Yang F; Liu YH; Dong SY; Ma RM; Bhandari A; Zhang XH; Wang OC
Biochem Biophys Res Commun; 2016 Feb; 470(3):479-483. PubMed ID: 26820525
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
Shi XM; Teng F
Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
[TBL] [Abstract][Full Text] [Related]
18. Downregulated long non-coding RNA MEG3 in breast cancer regulates proliferation, migration and invasion by depending on p53's transcriptional activity.
Sun L; Li Y; Yang B
Biochem Biophys Res Commun; 2016 Sep; 478(1):323-329. PubMed ID: 27166155
[TBL] [Abstract][Full Text] [Related]
19. Effects of long non-coding RNA H19 and microRNA let7a expression on thyroid cancer prognosis.
Liu N; Zhou Q; Qi YH; Wang H; Yang L; Fan QY
Exp Mol Pathol; 2017 Aug; 103(1):71-77. PubMed ID: 28655518
[TBL] [Abstract][Full Text] [Related]
20. Association of LncRNA MEG3 polymorphisms with efficacy of neoadjuvant chemotherapy in breast cancer.
Bayarmaa B; Wu Z; Peng J; Wang Y; Xu S; Yan T; Yin W; Lu J; Zhou L
BMC Cancer; 2019 Sep; 19(1):877. PubMed ID: 31488093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
